.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
Colorcon
Federal Trade Commission
Deloitte
McKesson
McKinsey
Harvard Business School
Baxter
US Department of Justice

Generated: June 25, 2017

DrugPatentWatch Database Preview

Carglumic acid - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carglumic acid and what is the scope of carglumic acid patent protection?

Carglumic acid
is the generic ingredient in one branded drug marketed by Orphan Europe and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for carglumic acid. One supplier is listed for this compound.

Summary for Generic Name: carglumic acid

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list42
Clinical Trials: see list4,796
Patent Applications: see list79
Drug Prices:see low prices
DailyMed Link:carglumic acid at DailyMed

Pharmacology for Ingredient: carglumic acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orphan Europe
CARBAGLU
carglumic acid
TABLET;ORAL022562-001Mar 18, 2010RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
AstraZeneca
Cantor Fitzgerald
Boehringer Ingelheim
Federal Trade Commission
Citi
Dow
McKesson
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot